Lynda Charters

Lowe syndrome, a genetic disease, affects about 1 in 500,000 people in the general population.

Structural and vascular changes detected in RVO-affected eyes and unaffected fellow eyes

Increased levels of p-tau181 and p-tau127 and a decreasing cerebrospinal fluid Aβ42/40 ratio better defines progression from preclinical to manifest Alzheimer’s disease.

AI matched and outshone human specialists.

Physicians offer pearls for the treatment of patients diagnosed with these diseases

A new study shows that much of an older person with visual impairment's physical activity is achieved at home. Improved home lighting can help increase those at-home activity rates.

Early keratoconus screening advocated

Teaching fellows can prove to be a rewarding experience for instructors.

Robert L Stamper, MD, raises the question of physician liability for allowing the patient to drive.

A new study found that only a little over half of school-aged children participants underwent vision screening within the past two years, highlighting gaps in eye care access.

The study further defined the relationship between delayed rod-mediated dark adaptation and the status of outer retinal bands on optical coherence tomography.

Elodie Bousquet, MD, PhD, and international researchers studied type 3 macular neovascularization (T3 MNV) using optical coherence tomography. In 64.5% of 31 eyes with T3 MNV, it developed over soft drusen, showing drusen growth and outer layer thinning before T3 MNV.

A minimum of 5,000 patients with up to 5 years of follow-up will be included in the study, with patients from a variety of practice settings and clinician experiences in 28 countries and 500 sites

Early-onset drusen maculopathy (EODM), is part of the age-related macular degeneration (AMD) phenotype that occurs in individuals under 55 years of age.

Multimodal technology bridges the gap between advanced age-related macular degeneration (AMD) biomarkers and clinical features.

A new study out of Guangzhou, China found that individuals younger than 18 years of age and experiencing high myopia are at a high risk of progressively worsening myopic maculopathy.

Ophthalmologist shares pearls from recent roundtable discussion on topic.

While the potential for fundus images is recognized, the methodology and clinical application must be improved.

A recent study found that despite worldwide reports of ocular inflammatory events being reported after patients received COVID-19 vaccinations, a low amount has been reported in the UK.

Genetic testing is proving to be an evolving technology for ophthalmologists.

Authors believe that PVI and PHMB are not associated with postoperative ocular irritation.

Evaluating injections of anti-VEGF drugs into the intra-anterior chamber may be a viable alternative, but further study is required.

Two retina specialists participated in an Ophthalmology Times case-based roundtable discussion and shared their experiences using the anti-VEGF biosimilars, ranibizumab-eqrn and ranibizumab-nuna to manage retinal diseases.

Consensus, awareness, and a CVI registry: top priorities of the trans-NIH event

Patients are encouraged to choose the optimal technology for their particular situation.